Psilocybin Drug Test

This test detects the presence of psilocybin and its primary active metabolite psilocin in urine. After ingestion, psilocybin is rapidly converted to psilocin, which is responsible for the psychoactive effects. The test provides a qualitative result indicating whether these metabolites are present above the assay cut-off level.

Psilocybin use may be associated with altered perception, impaired judgement, and psychological distress in some individuals. Detection can be relevant for clinical assessment, treatment monitoring, and forensic evaluations. Consult a healthcare professional for interpretation of results.

Testing may be relevant when psilocybin use is suspected, as part of extended drug screening panels, or during clinical evaluations. Psilocybin is not typically included in standard workplace drug tests, so targeted screening may be required. Consult a healthcare professional for guidance.